Yu Chen1,2, Fen Wu3,4, Eiko Saito5,6, Yingsong Lin7, Minkyo Song8, Hung N Luu9,10, Prakash C Gupta11, Norie Sawada6, Akiko Tamakoshi12, Xiao-Ou Shu9, Woon-Puay Koh13,14, Yong-Bing Xiang15, Yasutake Tomata16, Kemmyo Sugiyama16, Sue K Park17, Keitaro Matsuo18,19, Chisato Nagata20, Yumi Sugawara16, You-Lin Qiao21, San-Lin You22,23, Renwei Wang24, Myung-Hee Shin25, Wen-Harn Pan26, Mangesh S Pednekar11, Shoichiro Tsugane6, Hui Cai9, Jian-Min Yuan27,28, Yu-Tang Gao15, Ichiro Tsuji16, Seiki Kanemura16, Hidemi Ito19,29, Keiko Wada20, Yoon-Ok Ahn17, Keun-Young Yoo30, Habibul Ahsan31, Kee Seng Chia14, Paolo Boffetta32, Wei Zheng9, Manami Inoue5,6, Daehee Kang17,33,34, John D Potter35,36,37. 1. Department of Population Health, New York University School of Medicine, 650 First Avenue, Room 510, New York, NY, 10016, USA. yu.chen@nyumc.org. 2. Department of Environmental Medicine, New York University School of Medicine, Tuxedo Park, NY, 10987, USA. yu.chen@nyumc.org. 3. Department of Population Health, New York University School of Medicine, 650 First Avenue, Room 510, New York, NY, 10016, USA. 4. Department of Environmental Medicine, New York University School of Medicine, Tuxedo Park, NY, 10987, USA. 5. AXA Department of Health and Human Security, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. 6. Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan. 7. Department of Public Health, Aichi Medical University School of Medicine, Nagakute, Japan. 8. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 9. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. 10. Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, USA. 11. Healis Sekhsaria Institute for Public Health, Navi Mumbai, India. 12. Graduate School of Medicine, Hokkaido University, Sapporo, Japan. 13. Duke-NUS Medical School Singapore, Singapore, Republic of Singapore. 14. Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Republic of Singapore. 15. Shanghai Cancer Institute, Shanghai Jiaotong University, Shanghai, People's Republic of China. 16. Tohoku University Graduate School of Medicine, Miyagi Prefecture, Japan. 17. Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea. 18. Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. 19. Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. 20. Graduate School of Medicine, Gifu University, Gifu, Japan. 21. Cancer Foundation of China, Beijing, People's Republic of China. 22. School of Medicine, Fu-Jen Catholic University, Taipei, Taiwan. 23. Big Data Research Centre, Fu-Jen Catholic University, Taipei, Taiwan. 24. University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. 25. Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Seoul, South Korea. 26. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. 27. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. 28. Division of Cancer Control and Population Science, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. 29. Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan. 30. Armed Forces Capital Hospital, Seoul National University College of Medicine, Seoul, South Korea. 31. Department of Public Health Sciences, University of Chicago, Chicago, IL, USA. 32. Icahn School of Medicine at Mount Sinai, New York, NY, USA. 33. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea. 34. Cancer Research Institute, Seoul National University, Seoul, South Korea. 35. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 36. Centre for Public Health Research, Massey University, Wellington, New Zealand. 37. Department of Epidemiology, University of Washington, Seattle, WA, USA.
Abstract
AIMS/HYPOTHESIS: The aims of the study were to evaluate the association between type 2 diabetes and the risk of death from any cancer and specific cancers in East and South Asians. METHODS: Pooled analyses were conducted of 19 prospective population-based cohorts included in the Asia Cohort Consortium, comprising data from 658,611 East Asians and 112,686 South Asians. HRs were used to compare individuals with diabetes at baseline with those without diabetes for the risk of death from any cancer and from site-specific cancers, including cancers of the oesophagus, stomach, colorectum, colon, rectum, liver, bile duct, pancreas, lung, breast, endometrium, cervix, ovary, prostate, bladder, kidney and thyroid, as well as lymphoma and leukaemia. RESULTS: During a mean follow-up of 12.7 years, 37,343 cancer deaths (36,667 in East Asians and 676 in South Asians) were identified. Baseline diabetes status was statistically significantly associated with an increased risk of death from any cancer (HR 1.26; 95% CI 1.21, 1.31). Significant positive associations with diabetes were observed for cancers of the colorectum (HR 1.41; 95% CI 1.26, 1.57), liver (HR 2.05; 95% CI 1.77, 2.38), bile duct (HR 1.41; 95% CI 1.04, 1.92), gallbladder (HR 1.33; 95% CI 1.10, 1.61), pancreas (HR 1.53; 95% CI 1.32, 1.77), breast (HR 1.72; 95% CI 1.34, 2.19), endometrium (HR 2.73; 95% CI 1.53, 4.85), ovary (HR 1.60; 95% CI 1.06, 2.42), prostate (HR 1.41; 95% CI 1.09, 1.82), kidney (HR 1.84; 95% CI 1.28, 2.64) and thyroid (HR 1.99; 95% CI 1.03, 3.86), as well as lymphoma (HR 1.39; 95% CI 1.04, 1.86). Diabetes was not statistically significantly associated with the risk of death from leukaemia and cancers of the bladder, cervix, oesophagus, stomach and lung. CONCLUSIONS/ INTERPRETATION: Diabetes was associated with a 26% increased risk of death from any cancer in Asians. The pattern of associations with specific cancers suggests the need for better control (prevention, detection, management) of the growing epidemic of diabetes (as well as obesity), in order to reduce cancer mortality.
AIMS/HYPOTHESIS: The aims of the study were to evaluate the association between type 2 diabetes and the risk of death from any cancer and specific cancers in East and South Asians. METHODS: Pooled analyses were conducted of 19 prospective population-based cohorts included in the Asia Cohort Consortium, comprising data from 658,611 East Asians and 112,686 South Asians. HRs were used to compare individuals with diabetes at baseline with those without diabetes for the risk of death from any cancer and from site-specific cancers, including cancers of the oesophagus, stomach, colorectum, colon, rectum, liver, bile duct, pancreas, lung, breast, endometrium, cervix, ovary, prostate, bladder, kidney and thyroid, as well as lymphoma and leukaemia. RESULTS: During a mean follow-up of 12.7 years, 37,343 cancer deaths (36,667 in East Asians and 676 in South Asians) were identified. Baseline diabetes status was statistically significantly associated with an increased risk of death from any cancer (HR 1.26; 95% CI 1.21, 1.31). Significant positive associations with diabetes were observed for cancers of the colorectum (HR 1.41; 95% CI 1.26, 1.57), liver (HR 2.05; 95% CI 1.77, 2.38), bile duct (HR 1.41; 95% CI 1.04, 1.92), gallbladder (HR 1.33; 95% CI 1.10, 1.61), pancreas (HR 1.53; 95% CI 1.32, 1.77), breast (HR 1.72; 95% CI 1.34, 2.19), endometrium (HR 2.73; 95% CI 1.53, 4.85), ovary (HR 1.60; 95% CI 1.06, 2.42), prostate (HR 1.41; 95% CI 1.09, 1.82), kidney (HR 1.84; 95% CI 1.28, 2.64) and thyroid (HR 1.99; 95% CI 1.03, 3.86), as well as lymphoma (HR 1.39; 95% CI 1.04, 1.86). Diabetes was not statistically significantly associated with the risk of death from leukaemia and cancers of the bladder, cervix, oesophagus, stomach and lung. CONCLUSIONS/ INTERPRETATION:Diabetes was associated with a 26% increased risk of death from any cancer in Asians. The pattern of associations with specific cancers suggests the need for better control (prevention, detection, management) of the growing epidemic of diabetes (as well as obesity), in order to reduce cancer mortality.
Entities:
Keywords:
Asia Cohort Consortium; Asians; Cancer mortality; Meta-analysis; Type 2 diabetes
Authors: Juliana C N Chan; Vasanti Malik; Weiping Jia; Takashi Kadowaki; Chittaranjan S Yajnik; Kun-Ho Yoon; Frank B Hu Journal: JAMA Date: 2009-05-27 Impact factor: 56.272
Authors: K Waki; M Noda; S Sasaki; Y Matsumura; Y Takahashi; A Isogawa; Y Ohashi; T Kadowaki; S Tsugane Journal: Diabet Med Date: 2005-03 Impact factor: 4.359
Authors: Zhiguo Zhao; Wanqing Wen; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Ben Zhang; Jirong Long; Xiao-Ou Shu; Marjanka K Schmidt; Roger L Milne; Montserrat García-Closas; Jenny Chang-Claude; Sara Lindstrom; Stig E Bojesen; Habibul Ahsan; Kristiina Aittomäki; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Matthias W Beckmann; Alicia Beeghly-Fadiel; Javier Benitez; Carl Blomqvist; Natalia V Bogdanova; Anne-Lise Børresen-Dale; Judith Brand; Hiltrud Brauch; Hermann Brenner; Barbara Burwinkel; Qiuyin Cai; Graham Casey; Georgia Chenevix-Trench; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Thilo Dörk; Martine Dumont; Peter A Fasching; Jonine Figueroa; Dieter Flesch-Janys; Olivia Fletcher; Henrik Flyger; Florentia Fostira; Marilie Gammon; Graham G Giles; Pascal Guénel; Christopher A Haiman; Ute Hamann; Patricia Harrington; Mikael Hartman; Maartje J Hooning; John L Hopper; Anna Jakubowska; Farzana Jasmine; Esther M John; Nichola Johnson; Maria Kabisch; Sofia Khan; Muhammad Kibriya; Julia A Knight; Veli-Matti Kosma; Mieke Kriege; Vessela Kristensen; Loic Le Marchand; Eunjung Lee; Jingmei Li; Annika Lindblom; Artitaya Lophatananon; Robert Luben; Jan Lubinski; Kathleen E Malone; Arto Mannermaa; Siranoush Manoukian; Sara Margolin; Frederik Marme; Catriona McLean; Hanne Meijers-Heijboer; Alfons Meindl; Hui Miao; Kenneth Muir; Susan L Neuhausen; Heli Nevanlinna; Patrick Neven; Janet E Olson; Barbara Perkins; Paolo Peterlongo; Kelly-Anne Phillips; Katri Pylkäs; Anja Rudolph; Regina Santella; Elinor J Sawyer; Rita K Schmutzler; Minouk Schoemaker; Mitul Shah; Martha Shrubsole; Melissa C Southey; Anthony J Swerdlow; Amanda E Toland; Ian Tomlinson; Diana Torres; Thérèse Truong; Giske Ursin; Rob B Van Der Luijt; Senno Verhoef; Shan Wang-Gohrke; Alice S Whittemore; Robert Winqvist; M Pilar Zamora; Hui Zhao; Alison M Dunning; Jacques Simard; Per Hall; Peter Kraft; Paul Pharoah; David Hunter; Douglas F Easton; Wei Zheng Journal: Cancer Causes Control Date: 2016-04-06 Impact factor: 2.506
Authors: Naureen Javeed; Gunisha Sagar; Shamit K Dutta; Thomas C Smyrk; Julie S Lau; Santanu Bhattacharya; Mark Truty; Gloria M Petersen; Randal J Kaufman; Suresh T Chari; Debabrata Mukhopadhyay Journal: Clin Cancer Res Date: 2014-10-29 Impact factor: 12.531
Authors: X H Zhou; Q Qiao; B Zethelius; K Pyörälä; S Söderberg; A Pajak; C D A Stehouwer; R J Heine; P Jousilahti; G Ruotolo; P M Nilsson; G Calori; J Tuomilehto Journal: Diabetologia Date: 2010-05-21 Impact factor: 10.122
Authors: F M Shebl; G Andreotti; A Rashid; Y-T Gao; K Yu; M-C Shen; B-S Wang; Q Li; T-Q Han; B-H Zhang; J F Fraumeni; A W Hsing Journal: Br J Cancer Date: 2010-06-01 Impact factor: 7.640
Authors: Tsuyoshi Hamada; Natalia Khalaf; Chen Yuan; Ana Babic; Vicente Morales-Oyarvide; Zhi Rong Qian; Jonathan Andrew Nowak; Kimmie Ng; Peter Kraft; Douglas Adam Rubinson; Meir Jonathan Stampfer; Edward Luciano Giovannucci; Charles Stewart Fuchs; Shuji Ogino; Brian Matthew Wolpin Journal: J Gastroenterol Date: 2018-01-23 Impact factor: 7.527
Authors: Brook E Harmon; Yurii B Shvetsov; Unhee Lim; Cardella L Leak; Emily Rose N San Diego; Kristine R Monroe; Lynne R Wilkens; Loic Le Marchand Journal: Ethn Health Date: 2020-06-07 Impact factor: 2.772